July 2021 FDA Recall Drug by His Enterprise Inc
D-0770-2021 - Marketed without ANDA/NDA approval
This Class II drug recall was voluntarily initiated by His Enterprise Inc on July 20, 2021 for the product Drug. The FDA reported the reason for recall as marketed without anda/nda approval. The product was distributed Nationwide and the recall is currently ongoing.
Recall Number: D-0770-2021
Marketed without ANDA/NDA approval
07-20-2021
09-01-2021
N/A
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
HIS ENTERPRISE INC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
N/A
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
USA nationwide.
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Miss Slim, capsules, packaged in 10-count and 30-count box, Distributed by : His Enterprise Made in USA UPC 742137605030
Batch or Lot Expiration Information
Lot# all lots